[
    [
        {
            "time": "2020-01-03",
            "original_text": "Stocks with Solid Entry Points to Consider for 2020",
            "features": {
                "keywords": [
                    "Stocks",
                    "Solid Entry Points",
                    "Consider",
                    "2020"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Stocks with Solid Entry Points to Consider for 2020",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "2020 Preview: The year ahead in Bay Area biotech and health",
            "features": {
                "keywords": [
                    "2020 Preview",
                    "Bay Area",
                    "biotech",
                    "health"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech",
                    "health"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2020 Preview: The year ahead in Bay Area biotech and health",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "The year ahead in Bay Area biotech and health",
            "features": {
                "keywords": [
                    "year ahead",
                    "Bay Area",
                    "biotech",
                    "health"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotech",
                    "health"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The year ahead in Bay Area biotech and health",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "Is AbbVie (ABBV) Stock Outpacing Its Medical Peers This Year?",
            "features": {
                "keywords": [
                    "AbbVie",
                    "ABBV",
                    "Stock",
                    "Outpacing",
                    "Medical Peers"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Is AbbVie (ABBV) Stock Outpacing Its Medical Peers This Year?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "Want To Retire Early? Learn the Intelligent Investing Secret - January 03, 2020",
            "features": {
                "keywords": [
                    "Retire Early",
                    "Intelligent Investing Secret"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Want To Retire Early? Learn the Intelligent Investing Secret - January 03, 2020",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 3,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "4 Reasons Why You Should Invest in J&J (JNJ) Stock in 2020",
            "features": {
                "keywords": [
                    "Reasons",
                    "Invest",
                    "J&J",
                    "JNJ",
                    "Stock",
                    "2020"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "4 Reasons Why You Should Invest in J&J (JNJ) Stock in 2020",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "AbbVie Stock Is Poised To Become A Top Pharma — But Should You Buy It?",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Stock",
                    "Poised",
                    "Top Pharma",
                    "Buy"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Stock Is Poised To Become A Top Pharma — But Should You Buy It?",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-01-03",
            "original_text": "AbbVie to Present at the 38th Annual J.P. Morgan Healthcare Conference",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Present",
                    "J.P. Morgan",
                    "Healthcare Conference"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie to Present at the 38th Annual J.P. Morgan Healthcare Conference",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]